As of the latest Form 4 filed Jun 10, 2026.
What Strata Critical Medical, Inc. insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 12 most recent filings for SRTA.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | 2026-06-08 | Heyburn William A. Co-CEO and CFO | SSale | −31.7K | $5.87 | $186K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Cohen Amir Chief Accounting Officer | SSale | −4.66K | $5.87 | $27.3K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Tomkiel Melissa M. Co-CEO and General Counsel | SSale | −29.7K | $5.87 | $175K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Wunsch Scott M CEO, Logistics | SSale | −5.55K | $5.87 | $32.6K | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | Wunsch Scott M CEO, Logistics | FTax | −13.9K | $4.92 | $68.5K | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | Cohen Amir Chief Accounting Officer | FTax | −41.0K | $4.92 | $202K | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | Tomkiel Melissa M. Co-CEO and General Counsel | FTax | −322K | $4.92 | $1.58M | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-24 | Heyburn William A. Co-CEO and CFO | FTax | −302K | $4.92 | $1.48M | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | Wunsch Scott M CEO, Logistics | AAward | +57.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | Cohen Amir Chief Accounting Officer | AAward | +83.5K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | Tomkiel Melissa M. Co-CEO and General Counsel | AAward | +630K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-04-27 | 2026-04-23 | Heyburn William A. Co-CEO and CFO | AAward | +546K | $0.00 | $0.00 | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also SRTA’s full analysis or the market-wide insider trading feed. The tabs above jump to SRTA’s other SEC data.
Source: SEC Form 4 filings for SRTA, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.